ReviewFrontiers in neuroscience2022

ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease.

Grant A Krafft et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.